查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439977

封堵器 - 全球市場回顧、競爭格局、市場預測 (2030)

Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計 2024 年至 2030 年預測期內，全球封堵器市場規模將以 6.31% 的複合年增長率成長。 封堵器的需求主要是由患有各種慢性病的目標患者群體不斷增加所推動的。 此外，快速的技術發展、對微創手術 (MIS) 的需求不斷增加、微創手術有利的報銷方案以及老年人口的增加等，將有助於 2024-2030 年預測期內的整體市場成長。

咬合架市場動態

由於多種因素，封堵器市場的產品需求正在成長，其中主要因素之一是心血管疾病盛行率的增加。

例如，英國心臟基金會 (2023) 報告稱，到 2022 年，全球將有約 5.5 億人患有心臟病和循環系統疾病。 文件也顯示，到2022年，缺血性心臟病將成為最常見的心血管疾病之一，影響全球2億人，其次是周邊動脈（血管）疾病，將影響1.1億人，中風將影響1億人， 6000 萬人患有心房顫動。 心血管疾病的增加導致外科手術的增加，解閉塞裝置可去除動脈中的斑塊形成並治癒疾病。

微創手術比心臟直視手術疤痕更少、疼痛更少、癒合更快，因此對微創手術的需求正在導致封堵器市場需求的增加。 此外，封堵器可以幫助避免與手術相關的缺點，例如支架放置後的疤痕和發炎。

根據世界衛生組織 (WHO) (2022) 的數據，2020 年全球約有 226 萬人新診斷出乳癌。 同數據顯示，2020年新增肺癌221萬例、皮膚癌120萬例、攝護腺癌141萬例、胃癌109萬例。 對於一些無法透過手術切除腫瘤的患者來說，栓塞是一種安全的選擇，因為它會減少流向癌細胞的血流。 化療栓塞也是肝癌的一種安寧療護方法，它可以阻斷動脈並幫助將化療藥物保留在肝臟中。 因此，癌症發生率的增加可能會增加未來幾年對封堵裝置的需求。

因此，上述因素將導致未來幾年對封堵器的需求增加，從而提高預測期內（2024-2030 年）封堵器的整體市場成長。

然而，手術相關併發症、嚴格的監管框架等可能會對封堵器市場的成長帶來挑戰。

COVID-19 大流行對封堵器市場產生了重大影響。 造成這種情況的主要原因之一是世界各地嚴格的封鎖導致醫療保健系統的重組。 COVID-19 患者的治療也被列為優先事項。 患有各種慢性疾病，特別是瓣膜性心臟病的患者被認為是不緊急的，導致治療延誤。 此外，重症監護病房床位的短缺對某些手術（包括使用封堵裝置的治療）來說是一個真正的挑戰。 除了供應鏈限制和缺乏熟練專業人員外，設備分銷也受到限制，這反過來又影響了對封鎖設備的需求。 然而，隨著解封後活動的恢復和疫苗的接種，患者開始到醫院和診所接受各種慢性疾病的治療，包括癌症和心血管疾病，導致對封堵器的需求增加。設備市場已步入正軌。

咬合架細分市場分析

在封堵器市場的應用領域，神經系統類別預計將在 2023 年佔據重要的收入佔有率。

腦動脈瘤盛行率的上升以及利用先進技術的新產品的推出預計將推動整體市場的成長。

例如，根據腦動脈瘤基金會 2021 年的估計，美國每年約有 30,000 人患有腦動脈瘤破裂。

同一份文件指出，女性，尤其是 55 歲以上的女性，腦動脈瘤破裂的風險高於男性。 隨著人口老化的增加，預計這種風險在未來將會增加。

本報告研究和分析了全球封堵器市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第一章封堵器市場報告簡介

第 2 章封堵裝置市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估

第三章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章封堵器市場主要因素分析

  • 佔用設備市場驅動因素
  • 封堵器市場的限制與挑戰
  • 封閉的設備市場機會

第五章波特封堵器市場五力分析

第六章封堵器市場佈局

  • 產品類型
    • 栓塞裝置
    • 閉塞清除裝置
    • 支援設備
  • 依用途
    • 腫瘤
    • 心
    • 緊張
    • 其他
  • 按最終用戶
    • 醫院
    • 門診手術中心
  • 地區
    • 北美封堵器市場規模（2021-2030 年）
    • 歐洲封堵器市場規模（2021-2030 年）
    • 亞太地區封堵器市場規模（2021-2030 年）
    • 其他地區封堵器市場規模（2021-2030 年）

第七章封堵器市場公司及產品概況

  • Abbott
  • Acrostak Int.
  • Terumo Corporation
  • Edwards Lifesciences Corporation
  • Cordis
  • B. Braun SE
  • Cook
  • Medtronic
  • Cardinal Health
  • AngioDynamics
  • Integer Holdings Corporation
  • Acandis GmbH
  • Penumbra, Inc.
  • LeMaitre Vascular Inc.
  • Lepu Medical
  • Stryker
  • Boston Scientific Corporation
  • Artio Medical Inc.
  • KYOTO MEDICAL PLANNING Co., Ltd.
  • Kaneka Medix Corporation

第8章KOL瀏覽量

第 9 章專案方法

第 10 章關於 DelveInsight

第 11 章免責聲明與聯絡我們

Product Code: DIMDCL0658

Occlusion Devices Market By Product Type (Embolization Devices, Occlusion Removal Devices [Coil Retrievers, Stent Retrievers, And Others], And Support Devices), By Application (Oncology, Cardiology, Neurology, And Others), By End-User (Hospitals, Ambulatory Surgical Centres, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of cardiovascular diseases, cancers, and other chronic diseases and the rising technological advancements in the occlusion devices

The global occlusion devices market is estimated to grow at a CAGR of 6.31% during the forecast period from 2024 to 2030. The demand for occlusion devices is primarily being boosted by the increasing number of target patient populations suffering from various chronic illnesses. Furthermore, surging technological developments, rising demand for minimally invasive surgeries (MIS), suitable reimbursement scenarios for minimally invasive surgeries, and an increasing geriatric population among others have contributed to the overall growth of the occlusion devices market during the forecast period from 2024-2030.

Occlusion Devices Market Dynamics:

The occlusion devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of cardiovascular diseases.

For instance, British Heart Foundation (2023) reported that around 550 million people were living with heart and circulatory diseases in 2022, across the world. Further, the source stated that ischemic heart disease is one of the most common cardiovascular disorders, affecting 200 million people, followed by peripheral arterial (vascular) disease with 110 million people, stroke with 100 million people, and atrial fibrillation affecting 60 million people in 2022, globally. The increasing number of cardiovascular diseases will in turn increase the number of surgical procedures in which the occlusion removal devices will aid by removing the plaque formation in the arteries, thereby curing the ailment.

The demand for minimally invasive surgeries that offer less scarring reduced pain, and faster healing than open-heart surgeries has led to the growth of demand for occlusion devices in the market. Furthermore, occlusion devices help in avoiding disadvantages associated with surgical procedures such as surgical scarring and inflammation after stent implantation.

According to the World Health Organization (WHO) 2022, it was stated that approximately 2.26 million new instances of breast cancer were diagnosed worldwide, in 2020. According to the same source, 2.21 million new cases of lung cancer, 1.20 million cases of skin cancer, 1.41 million cases of prostate cancer, and 1.09 million cases of stomach cancer were reported worldwide, in 2020. Embolization is known to be a safe option for some patients with tumors that cannot be removed by surgery as these devices reduce the blood flow to cancer cells. Also, chemoembolization is a palliative treatment for liver cancer that helps in blocking the artery to let the chemotherapy drug stay in the liver. Thus, the increasing incidence of cancer will increase the demand for occlusion devices in the upcoming years.

Therefore, the factors mentioned above will lead to an increased demand for occlusion devices in the upcoming years, thereby raising the overall market growth for occlusion devices during the forecast period (2024-2030).

However, surgery-related complications, stringent regulatory framework, and others can impose a challenge to occlusion device market growth.

The COVID-19 pandemic had significantly impacted the occlusion devices market one of the major reasons being the reorganization of healthcare systems owing to strict lockdown imposition across the globe. Also, the treatment of patients suffering from covid-19 infection was a priority. Patients suffering from various chronic diseases, particularly those with heart valve diseases were considered non-urgent which led to delays in their treatment procedures. Further, the shortage of ICU beds also possessed a real challenge for several procedures involving occlusion device treatments. Along with the restriction in the supply chain and shortage of skilled professionals, there was a limit in the distribution of devices which ultimately affected the demand for occlusion devices. However, with the resumption of activities after the relaxation of the lockdown and with the vaccine administration, the patients started visiting hospitals and clinics for the treatment of various chronic diseases including cancer and cardiovascular diseases, leading to an increased demand for occlusion devices, thereby bring the market of occlusion devices on track.

Occlusion Devices Market Segment Analysis:

Occlusion Devices Market by Product Type (Embolization Devices, Occlusion Removal Devices [Coil Retrievers, Stent Retrievers, and Others], and Support Devices), Application (Oncology, Cardiology, Vascular Diseases, Neurology, and Others), End-User (Hospitals, Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the occlusion devices market, the neurology category is expected to amass a significant revenue share in the year 2023.

The rising prevalence of brain aneurysms and the launch of new technologically advanced products are expected to drive the overall growth of the market.

For instance, according to 2021 estimations done by the Brain Aneurysm Foundation, approximately 30,000 people in the United States suffer a brain aneurysm rupture each year.

The same source stated that women, particularly those over the age of 55, have a higher risk of brain aneurysm rupture than men. This risk is expected to increase in the future as the geriatric population increases.

Further, blood artery damage or trauma, smoking, hypertension, and genetic susceptibility are all risk factors for the development of a brain aneurysm. Medical therapy, surgical clipping, endovascular therapy, or coiling without or with adjunctive devices are among the options for treating brain aneurysms. For instance, according to the WHO key statistics from August 2021, there were an estimated 1.28 billion adults worldwide, aged 30-79, who had hypertension, with the majority of them (two-thirds) residing in low- and middle-income countries. The increasing statistics of hypertension will increase the number of patients suffering from cardiovascular diseases, ultimately increasing the demand for occlusion devices used in the treatment of cardiovascular diseases.

Hence, owing to all the aforementioned factors, the market will experience an increased demand for neurology occlusion devices, thus growing the occlusion devices market during the forecast period.

North America is expected to dominate the overall Occlusion Devices Market:

Among all the regions, North America is estimated to account for the largest share of the occlusion devices market in the year 2023. Owing to key growth factors such as the rising prevalence of cardiovascular diseases, increasing cases of cancer, as well as neurological conditions like brain aneurysms, along with the soaring advancement in devices, and newer government initiatives regarding disease treatment awareness, are driving the North America occlusion devices market.

For instance, the Centers for Disease Control and Prevention (CDC) 2022, reported that every year, about 805,000 people in the United States suffer from heart attacks, especially among most racial and ethnic groups in the United States. As per, CDC 2021, about 18.2 million adults of age 20 years and older had coronary artery disease, and about 360,900 people died in 2019 due to coronary heart disease. As a result, more operations are anticipated due to the high mortality rate from cardiovascular diseases in the nation. This will likely lead to a rise in the usage of occlusion devices and support the expansion of the market.

Moreover, the rising prevalence of cancer in the US is also considered a key factor in the growing demand for occlusion devices.

In 2023, the American Cancer Society reported that in the United States 2023, nearly 1,958,310 new cancer cases are projected to occur. The increasing incidence of cancer is expected to drive the demand for interventional procedures in the region, thereby increasing the demand for occlusion devices as these devices work by stopping the blood flow toward tumors.

Therefore, the presence of a massive patient population suffering from various diseases correlates with an increase in product demand which supports the growth of the United States occlusion devices market as well as the overall North America occlusion devices market during the forecast period from 2024-2030.

Hence, the above-mentioned factors are going to generate considerable revenue thereby pushing the overall growth of the occlusion devices market in the North America region during the forecast period.

Occlusion Devices Market Key Players:

Some of the key market players operating in the occlusion devices market include Abbott, Acrostak Int., Terumo Corporation, Edwards Lifesciences Corporation, Cordis, B. Braun SE, Cook, Medtronic, Cardinal Health, AngioDynamics, Integer Holdings Corporation, Acandis GmbH, Penumbra, Inc., LeMaitre Vascular Inc., Lepu Medical, Stryker, Boston Scientific Corporation, Artio Medical Inc., KYOTO MEDICAL PLANNING Co., Ltd., Kaneka Medix Corporation, and others.

Recent Developmental Activities in the Occlusion Devices Market:

In February 2022, Front Line Medical Technologies announced the availability and distribution of COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System) which is strong enough to hold back aortic pressure and allows for permissive hypotension in bleeding areas below the balloon, thus decreasing chances of hemorrhage. It is the smallest life-saving bleeding control device.

In July 2021, Terumo Medical Corporation (TMC) announced the introduction of its AZUR Vascular Plug, the only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter.

In September 2020, Boston Scientific Corporation received U.S. Food & Drug Administration (FDA) approval to launch WATCHMAN FLX, which is a Left Atrial Appendage Closure (LAAC) device. It is designed to seal off Heart's left atrial appendage to prevent blood clot formation.

Key Takeaways from the Occlusion Devices Market Report Study

Market size analysis for current occlusion devices market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global occlusion devices market.

Various opportunities available for the other competitor in the occlusion devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current occlusion devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for occlusion devices market growth in the coming future?

Target Audience who can be benefited from this Occlusion Devices Market Report Study

Occlusion devices products providers

Research organizations and consulting companies

Occlusion devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in occlusion devices

Various End-users who want to know more about the occlusion devices market and the latest technological developments in the occlusion devices market.

Frequently Asked Questions for the Occlusion Devices Market:

1. What is an occlusion device?

Occlusion devices are used to create occlusion in the vessels to stop the blood flow.

2. What is the market for global occlusion devices?

The global occlusion devices market is estimated to grow at a CAGR of 6.31% during the forecast period from 2024 to 2030.

3. What are the drivers for global occlusion devices market?

The demand for occlusion devices is primarily being boosted by the rising prevalence of cardiovascular diseases, cancers, and other chronic diseases. Further, the rising adoption of minimally invasive devices, increasing geriatric population base, innovations in product development, and others will increase the demand for the overall growth of the occlusion devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global occlusion devices market?

Some of the key market players operating in the occlusion devices market include Abbott, Acrostak Int., Terumo Corporation, Edwards Lifesciences Corporation, Cordis, B. Braun SE, Cook, Medtronic, Cardinal Health, AngioDynamics, Integer Holdings Corporation, Acandis GmbH, Penumbra, Inc., LeMaitre Vascular Inc., Lepu Medical, Stryker, Boston Scientific Corporation, Artio Medical Inc., KYOTO MEDICAL PLANNING Co., Ltd., Kaneka Medix Corporation, and others.

5. Which region has the highest share in the occlusion devices market?

North America is expected to dominate the overall occlusion devices market during the forecast period, 2024 to 2030. Factors such as the rising prevalence of cardiovascular diseases, cancers, and other chronic diseases, the rising geriatric population, and better healthcare infrastructure have had an immense effect on the growth of occlusion devices in the North America market. Furthermore, the rise in research to validate the efficacy of occlusion devices and the growing preference for minimally invasive devices also helped the market growth in this region.

Table of Contents

1.Occlusion Devices Market Report Introduction

2. Occlusion Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Occlusion Devices Market Key Factors Analysis

  • 4.1. Occlusion Devices Market Drivers
    • 4.1.1. Rising number of surgical procedures owing to the increasing number of chronic diseases
    • 4.1.2. Increasing preference for minimally invasive surgery
    • 4.1.3. Technological advancements in product development
  • 4.2. Occlusion Devices Market Restraints and Challenges
    • 4.2.1. Surgery-Related Complications
    • 4.2.2. Stringent regulatory framework
  • 4.3. Occlusion Devices Market Opportunities
    • 4.3.1. Advancements in the materials and configurations of occlusion devices

5. Occlusion Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Occlusion Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Embolization Devices
    • 6.1.2. Occlusion Removal Devices
      • 6.1.2.1. Coil Retrievers
      • 6.1.2.2. Stent Retrievers
      • 6.1.2.3. Others
    • 6.1.3. Support Devices
  • 6.2. By Application
    • 6.2.1. Oncology
    • 6.2.2. Cardiology
    • 6.2.3. Neurology
    • 6.2.4. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.1. France Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.1. China Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of the Asia-Pacific Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Occlusion Devices Market Size in USD million (2021-2030)

7. Occlusion Devices Market Company and Product Profiles

    • 7.1.1. Abbott
      • 7.1.1.1. Company Overview
      • 7.1.1.2. Company Snapshot
      • 7.1.1.3. Financial Overview
      • 7.1.1.4. Product Listing
      • 7.1.1.5. Entropy
    • 7.1.2. Acrostak Int.
      • 7.1.2.1. Company Overview
      • 7.1.2.2. Company Snapshot
      • 7.1.2.3. Financial Overview
      • 7.1.2.4. Product Listing
      • 7.1.2.5. Entropy
    • 7.1.3. Terumo Corporation
      • 7.1.3.1. Company Overview
      • 7.1.3.2. Company Snapshot
      • 7.1.3.3. Financial Overview
      • 7.1.3.4. Product Listing
      • 7.1.3.5. Entropy
    • 7.1.4. Edwards Lifesciences Corporation
      • 7.1.4.1. Company Overview
      • 7.1.4.2. Company Snapshot
      • 7.1.4.3. Financial Overview
      • 7.1.4.4. Product Listing
      • 7.1.4.5. Entropy
    • 7.1.5. Cordis
      • 7.1.5.1. Company Overview
      • 7.1.5.2. Company Snapshot
      • 7.1.5.3. Financial Overview
      • 7.1.5.4. Product Listing
      • 7.1.5.5. Entropy
    • 7.1.6. B. Braun SE
      • 7.1.6.1. Company Overview
      • 7.1.6.2. Company Snapshot
      • 7.1.6.3. Financial Overview
      • 7.1.6.4. Product Listing
      • 7.1.6.5. Entropy
    • 7.1.7. Cook
      • 7.1.7.1. Company Overview
      • 7.1.7.2. Company Snapshot
      • 7.1.7.3. Financial Overview
      • 7.1.7.4. Product Listing
      • 7.1.7.5. Entropy
    • 7.1.8. Medtronic
      • 7.1.8.1. Company Overview
      • 7.1.8.2. Company Snapshot
      • 7.1.8.3. Financial Overview
      • 7.1.8.4. Product Listing
      • 7.1.8.5. Entropy
    • 7.1.9. Cardinal Health
      • 7.1.9.1. Company Overview
      • 7.1.9.2. Company Snapshot
      • 7.1.9.3. Financial Overview
      • 7.1.9.4. Product Listing
      • 7.1.9.5. Entropy
    • 7.1.10. AngioDynamics
      • 7.1.10.1. Company Overview
      • 7.1.10.2. Company Snapshot
      • 7.1.10.3. Financial Overview
      • 7.1.10.4. Product Listing
      • 7.1.10.5. Entropy
    • 7.1.11. Integer Holdings Corporation
      • 7.1.11.1. Company Overview
      • 7.1.11.2. Company Snapshot
      • 7.1.11.3. Financial Overview
      • 7.1.11.4. Product Listing
      • 7.1.11.5. Entropy
    • 7.1.12. Acandis GmbH
      • 7.1.12.1. Company Overview
      • 7.1.12.2. Company Snapshot
      • 7.1.12.3. Financial Overview
      • 7.1.12.4. Product Listing
      • 7.1.12.5. Entropy
    • 7.1.13. Penumbra, Inc.
      • 7.1.13.1. Company Overview
      • 7.1.13.2. Company Snapshot
      • 7.1.13.3. Financial Overview
      • 7.1.13.4. Product Listing
      • 7.1.13.5. Entropy
    • 7.1.14. LeMaitre Vascular Inc.
      • 7.1.14.1. Company Overview
      • 7.1.14.2. Company Snapshot
      • 7.1.14.3. Financial Overview
      • 7.1.14.4. Product Listing
      • 7.1.14.5. Entropy
    • 7.1.15. Lepu Medical
      • 7.1.15.1. Company Overview
      • 7.1.15.2. Company Snapshot
      • 7.1.15.3. Financial Overview
      • 7.1.15.4. Product Listing
      • 7.1.15.5. Entropy
    • 7.1.16. Stryker
      • 7.1.16.1. Company Overview
      • 7.1.16.2. Company Snapshot
      • 7.1.16.3. Financial Overview
      • 7.1.16.4. Product Listing
      • 7.1.16.5. Entropy
    • 7.1.17. Boston Scientific Corporation
      • 7.1.17.1. Company Overview
      • 7.1.17.2. Company Snapshot
      • 7.1.17.3. Financial Overview
      • 7.1.17.4. Product Listing
      • 7.1.17.5. Entropy
    • 7.1.18. Artio Medical Inc.
      • 7.1.18.1. Company Overview
      • 7.1.18.2. Company Snapshot
      • 7.1.18.3. Financial Overview
      • 7.1.18.4. Product Listing
      • 7.1.18.5. Entropy
    • 7.1.19. KYOTO MEDICAL PLANNING Co., Ltd.
      • 7.1.19.1. Company Overview
      • 7.1.19.2. Company Snapshot
      • 7.1.19.3. Financial Overview
      • 7.1.19.4. Product Listing
      • 7.1.19.5. Entropy
    • 7.1.20. Kaneka Medix Corporation
      • 7.1.20.1. Company Overview
      • 7.1.20.2. Company Snapshot
      • 7.1.20.3. Financial Overview
      • 7.1.20.4. Product Listing
      • 7.1.20.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Occlusion Devices Market in Global (2021-2030)
  • Table 3: Occlusion Devices Market in Global by Product Type (2021-2030)
  • Table 4: Occlusion Devices Market in Global by Application (2021-2030)
  • Table 5: Occlusion Devices Market in Global by End-User (2021-2030)
  • Table 6: Occlusion Devices Market in Global by Geography (2021-2030)
  • Table 7: Occlusion Devices Market in North America (2021-2030)
  • Table 8: Occlusion Devices Market in North America by Country (2021-2030)
  • Table 9: Occlusion Devices Market in the US (2021-2030)
  • Table 10: Occlusion Devices Market in Canada (2021-2030)
  • Table 11: Occlusion Devices Market in Mexico (2021-2030)
  • Table 12: Occlusion Devices Market in Europe (2021-2030)
  • Table 13: Occlusion Devices Market in Europe by Country (2021-2030)
  • Table 14: Occlusion Devices Market in France (2021-2030)
  • Table 15: Occlusion Devices Market in Germany (2021-2030)
  • Table 16: Occlusion Devices Market in the United Kingdom (2021-2030)
  • Table 17: Occlusion Devices Market in Italy (2021-2030)
  • Table 18: Occlusion Devices Market in Spain (2021-2030)
  • Table 19: Occlusion Devices Market in the Rest of Europe (2021-2030)
  • Table 20: Occlusion Devices Market in Asia-Pacific (2021-2030)
  • Table 21: Occlusion Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 22: Occlusion Devices Market in China (2021-2030)
  • Table 23: Occlusion Devices Market in Japan (2021-2030)
  • Table 24: Occlusion Devices Market in India (2021-2030)
  • Table 25: Occlusion Devices Market in Australia (2021-2030)
  • Table 26: Occlusion Devices Market in South Korea (2021-2030)
  • Table 27: Occlusion Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 28: Occlusion Devices Market in the Rest of the World (2021-2030)
  • Table 29: Occlusion Devices Market in RoW by Region (2021-2030)
  • Table 30: Occlusion Devices Market in the Middle East (2021-2030)
  • Table 31: Occlusion Devices Market in Africa (2021-2030)
  • Table 32: Occlusion Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Occlusion Devices Market in Global (2021-2030)
  • Figure 3: Occlusion Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Occlusion Devices Market in Global by Application (2021-2030)
  • Figure 5: Occlusion Devices Market in Global by End-User (2021-2030)
  • Figure 6: Occlusion Devices Market in Global by Geography (2021-2030)
  • Figure 7: Occlusion Devices Market in North America (2021-2030)
  • Figure 8: Occlusion Devices Market in North America by Country (2021-2030)
  • Figure 9: Occlusion Devices Market in the US (2021-2030)
  • Figure 10: Occlusion Devices Market in Canada (2021-2030)
  • Figure 11: Occlusion Devices Market in Mexico (2021-2030)
  • Figure 12: Occlusion Devices Market in Europe (2021-2030)
  • Figure 13: Occlusion Devices Market in Europe by Country (2021-2030)
  • Figure 14: Occlusion Devices Market in France (2021-2030)
  • Figure 15: Occlusion Devices Market in Germany (2021-2030)
  • Figure 16: Occlusion Devices Market in the United Kingdom (2021-2030)
  • Figure 17: Occlusion Devices Market in Italy (2021-2030)
  • Figure 18: Occlusion Devices Market in Spain (2021-2030)
  • Figure 19: Occlusion Devices Market in the Rest of Europe (2021-2030)
  • Figure 20: Occlusion Devices Market in Asia-Pacific (2021-2030)
  • Figure 21: Occlusion Devices Market in Asia-Pacific by Country (2021-2030)
  • Figure 22: Occlusion Devices Market in China (2021-2030)
  • Figure 23: Occlusion Devices Market in Japan (2021-2030)
  • Figure 24: Occlusion Devices Market in India (2021-2030)
  • Figure 25: Occlusion Devices Market in Australia (2021-2030)
  • Figure 26: Occlusion Devices Market in South Korea (2021-2030)
  • Figure 27: Occlusion Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 28: Occlusion Devices Market in the Rest of the World (2021-2030)
  • Figure 29: Occlusion Devices Market in RoW by Region (2021-2030)
  • Figure 30: Occlusion Devices Market in the Middle East (2021-2030)
  • Figure 31: Occlusion Devices Market in Africa (2021-2030)
  • Figure 32: Occlusion Devices Market in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Marker Opportunities
  • Figure 36: PORTER'S Five Force Analysis